C. Lagheden

发表

HPV transcription in skin tumors

J. Dillner, E. Hultin, L. S. Arroyo Mühr, 2019, PloS one.

Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point—registry-based follow-up of three cohorts from randomized trials

M. Lehtinen, J. Dillner, D. Apter, 2017, BMJ Open.

Human Papillomavirus Infection Determines Prognosis in Cervical Cancer

P. Sparén, J. Dillner, C. Eklund, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Audit of laboratory sensitivity of human papillomavirus and cytology testing in a cervical screening program

Maria Hortlund, J. Dillner, A. Hjerpe, 2021, International journal of cancer.

Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening

J. Dillner, K. Cuschieri, R. Bhatia, 2020, BMC Cancer.

Nonvaccine human papillomavirus genotype common in women with HIV failing cervical precancer treatment

P. Sparén, J. Dillner, C. Eklund, 2021, AIDS.

Metatranscriptome analysis in human papillomavirus negative cervical cancers

L. S. Arroyo Mühr, C. Lagheden, A. Ure, 2022, Scientific Reports.

HPV Types in Cervical Precancer by HIV Status and Birth Region: A Population-Based Register Study

P. Sparén, J. Dillner, A. Sönnerborg, 2020, Cancer Epidemiology, Biomarkers & Prevention.

Human papillomavirus vaccine efficacy against invasive, HPV-positive cancers: population-based follow-up of a cluster-randomised trial

M. Lehtinen, J. Dillner, D. Apter, 2021, BMJ Open.

Decline of HPV infections in Scandinavian cervical screening populations after introduction of HPV vaccination programs.

Maria Hortlund, J. Dillner, S. Kjaer, 2018, Vaccine.

Nationwide comprehensive human papillomavirus (HPV) genotyping of invasive cervical cancer

P. Sparén, J. Dillner, C. Eklund, 2018, British Journal of Cancer.

De novo sequence assembly requires bioinformatic checking of chimeric sequences

J. Dillner, E. Hultin, Sara Nordqvist Kleppe, 2020, PloS one.

Does human papillomavirus-negative condylomata exist?

Joakim Dillner, Davit Bzhalava, Hanna Johansson, 2015, Virology.

Human papillomavirus type 197 is commonly present in skin tumors

Joakim Dillner, Davit Bzhalava, Hanna Johansson, 2015, International journal of cancer.

Deep sequencing extends the diversity of human papillomaviruses in human skin

Joakim Dillner, Davit Bzhalava, Johanna Ekström, 2014, Scientific Reports.

Human papillomavirus types in cervical high‐grade lesions or cancer among Nordic women—Potential for prevention

Maria Hortlund, J. Dillner, S. Kjaer, 2019, Cancer medicine.

Viruses in cancers among the immunosuppressed

Maria Hortlund, J. Dillner, D. Bzhalava, 2017, International journal of cancer.

Validation of a standardized extraction method for formalin-fixed paraffin-embedded tissue samples.

J. Dillner, E. Unger, C. Eklund, 2016, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Deep sequencing detects human papillomavirus (HPV) in cervical cancers negative for HPV by PCR

P. Sparén, J. Dillner, C. Eklund, 2020, British Journal of Cancer.

Differing Age-Specific Cervical Cancer Incidence Between Different Types of Human Papillomavirus: Implications for Predicting the Impact of Elimination Programs

P. Sparén, M. Lehtinen, J. Dillner, 2020, American journal of epidemiology.

Sequencing detects human papillomavirus in some apparently HPV-negative invasive cervical cancers.

P. Sparén, J. Dillner, C. Eklund, 2019, The Journal of general virology.

Cervical screening and risk of adenosquamous and rare histological types of invasive cervical carcinoma: population based nested case-control study

P. Sparén, J. Dillner, A. Ploner, 2019, BMJ.

High-risk human papillomavirus status and prognosis in invasive cervical cancer: A nationwide cohort study

P. Sparén, J. Dillner, A. Ploner, 2018, PLoS medicine.

The HPV16 genome is stable in women who progress to in situ or invasive cervical cancer: a prospective population-based study.

H. Adami, J. Dillner, E. Hultin, 2019, Cancer research.

Human papillomavirus type 16 genomic variation in women with subsequent in situ or invasive cervical cancer: prospective population-based study

H. Adami, J. Dillner, E. Hultin, 2018, British Journal of Cancer.

Viremia preceding multiple sclerosis: Two nested case-control studies.

Maria Hortlund, J. Dillner, E. Hultin, 2018, Virology.

The 2019 HPV Labnet international proficiency study: Need of global Human Papillomavirus Proficiency Testing.

J. Dillner, O. Forslund, C. Eklund, 2021, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Head-to-Head Comparison of Bi- and Nonavalent Human Papillomavirus Vaccine-Induced Antibody Responses

M. Lehtinen, J. Dillner, V. Pimenoff, 2022, The Journal of infectious diseases.

Systematic evaluation of SARS‐CoV‐2 antigens enables a highly specific and sensitive multiplex serological COVID‐19 assay

H. Tegel, P. Nilsson, J. Dillner, 2021, Clinical & translational immunology.

Human papillomavirus genotype-specific risks for cervical intraepithelial lesions

Maria Hortlund, J. Dillner, S. Kjaer, 2020, Human vaccines & immunotherapeutics.

Occurrence of human papillomavirus (HPV) type replacement by sexual risk‐taking behaviour group: Post‐hoc analysis of a community randomized clinical trial up to 9 years after vaccination (IV)

M. Lehtinen, J. Dillner, Simopekka Vänskä, 2019, International journal of cancer.

Improving human papillomavirus (HPV) testing in the cervical cancer elimination era: The 2021 HPV LabNet international proficiency study

J. Dillner, O. Forslund, C. Eklund, 2022, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Human papillomavirus type 197 is commonly present in skin tumors

J. Dillner, D. Bzhalava, E. Hultin, 2015, International journal of cancer.

Human papillomavirus negative high grade cervical lesions and cancers: Suggested guidance for HPV testing quality assurance.

T. Querec, Kristiane Søreng, C. Eklund, 2024, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Impact of cervical screening by human papillomavirus genotype: Population-based estimations

P. Sparén, C. Eklund, K. Sundström, 2023, PLoS medicine.

First international proficiency study on human papillomavirus testing in cervical cancer screening.

J. Dillner, C. Eklund, L. S. Arroyo Mühr, 2023, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Ecological diversity profiles of non-vaccine-targeted HPVs after gender-based community vaccination efforts.

V. Pimenoff, Tiina Eriksson, C. Lagheden, 2023, Cell host & microbe.

Concomitant human papillomavirus (HPV) vaccination and screening for elimination of HPV and cervical cancer

E. Hultin, K. Elfström, I. Baussano, 2024, Nature communications.

Low methylation marker levels among human papillomavirus-vaccinated women with cervical high-grade squamous intraepithelial lesions.

B. Nedjai, V. Pimenoff, D. Ścibior-Bentkowska, 2024, International journal of cancer.